Lipella Pharmaceuticals Inc. (LIPO) Net income 2021–2024
Lipella Pharmaceuticals Inc. (LIPO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$5.0MFY2024 · since FY2021: -$1.9M → -$5.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$5.0M | -8.6% |
| FY2023 | -$4.6M | -77.8% |
| FY2022 | -$2.6M | -39.3% |
| FY2021 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LIPO financial trends
LIPO RevenueLIPO Net marginLIPO Gross profitLIPO Gross marginLIPO Operating incomeLIPO Operating marginLIPO Operating cash flowLIPO Free cash flowLIPO Capital expendituresLIPO Return on equityLIPO Stock buybacksLIPO Dividends paidLIPO Total assetsLIPO Total liabilitiesLIPO Shareholders’ equityLIPO overview →